Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spravchikov, N.
Right arrow Articles by Wertheimer, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spravchikov, N.
Right arrow Articles by Wertheimer, E.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes 50:1627-1635, 2001
© 2001 by the American Diabetes Association, Inc.

Glucose Effects on Skin Keratinocytes

Implications for Diabetes Skin Complications

Natalia Spravchikov1, Galina Sizyakov1, Marina Gartsbein2, Domenico Accili3, Tamar Tennenbaum2, and Efrat Wertheimer1

1 Department of Pathology, Sackler School of Medicine, Tel Aviv University, Tel Aviv
2 Faculty of Life Sciences, Bar Ilan University, Ramat Gan, Israel
3 Columbia University/Berrie Research Pavilion, New York, New York

Altered skin wound healing is a common cause of morbidity and mortality among diabetic patients. However, the molecular mechanisms whereby diabetes alters skin physiology have not been elucidated. In this study, we investigated the relative roles of hyperglycemia, insulin, and IGF-I, all of which are abnormal in diabetes, in primary murine skin keratinocytes. These cells proliferate and differentiate in vitro in a manner similar to skin in vivo. It was found that in the presence of high glucose (20 mmol/l), the glucose transport rate of primary proliferating or differentiating keratinocytes was downregulated, whereas at 2 mmol/l glucose, the transport rate was increased. These changes were associated with changes in the GLUT1 expression and with changes in the affinity constant (Km) of the transport. Exposure to high glucose was associated with changes in cellular morphology, as well as with decreased proliferation and enhancement of Ca2+-induced differentiation of keratinocytes. Furthermore, in the presence of high glucose, ligand-induced IGF-I receptor but not insulin receptor (IR) autophosphorylation was decreased. Consequently, in high glucose, the effects of IGF-I on glucose uptake and keratinocyte proliferation were inhibited. Interestingly, lack of IR expression in IR-null keratinocytes abolished insulin-induced glucose uptake and partially decreased insulin- and IGF-I–induced proliferation, demonstrating the direct involvement of the IR in these processes. Our results demonstrate that hyperglycemia and impaired insulin signaling might be directly involved in the development of chronic complications of diabetes by impairing glucose utilization of skin keratinocytes as well as skin proliferation and differentiation.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
I. Goren, E. Muller, J. Pfeilschifter, and S. Frank
Severely Impaired Insulin Signaling in Chronic Wounds of Diabetic ob/ob Mice: A Potential Role of Tumor Necrosis Factor-{alpha}
Am. J. Pathol., March 1, 2006; 168(3): 765 - 777.
[Abstract] [Full Text] [PDF]


Home page
INT J LOW EXTREM WOUNDSHome page
T. L. Dinh and A. Veves
A Review of the Mechanisms Implicated in the Pathogenesis of the Diabetic Foot
International Journal of Lower Extremity Wounds, September 1, 2005; 4(3): 154 - 159.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
M. Sadagurski, G. Weingarten, C. J. Rhodes, M. F. White, and E. Wertheimer
Insulin Receptor Substrate 2 Plays Diverse Cell-specific Roles in the Regulation of Glucose Transport
J. Biol. Chem., April 15, 2005; 280(15): 14536 - 14544.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. Lobmann, G. Schultz, and H. Lehnert
Proteases and the Diabetic Foot Syndrome: Mechanisms and Therapeutic Implications
Diabetes Care, February 1, 2005; 28(2): 461 - 471.
[Full Text] [PDF]


Home page
Endocr. Rev.Home page
S. R. Edmondson, S. P. Thumiger, G. A. Werther, and C. J. Wraight
Epidermal Homeostasis: The Role of the Growth Hormone and Insulin-Like Growth Factor Systems
Endocr. Rev., December 1, 2003; 24(6): 737 - 764.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
I. S. Zagon, J. B. Jenkins, J. W. Sassani, J. D. Wylie, T. B. Ruth, J. L. Fry, C. M. Lang, and P. J. McLaughlin
Naltrexone, an Opioid Antagonist, Facilitates Reepithelialization of the Cornea in Diabetic Rat
Diabetes, October 1, 2002; 51(10): 3055 - 3062.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2001 by the American Diabetes Association.